Home > Research > Publications & Outputs > GLP-1 receptor agonists for Parkinson's disease...

Electronic data

  • CD012990

    Rights statement: This is the Publisher version of record of the following article: Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley HC. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012990. DOI: 10.1002/14651858.CD012990 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012990 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 221 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

GLP-1 receptor agonists for Parkinson's disease (Protocol)

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
  • Caroline A. Mulvaney
  • Gonçalo S. Duarte
  • Suresh Menon
  • Joel Handley
  • Hedley Emsley
Close
<mark>Journal publication date</mark>29/03/2018
<mark>Journal</mark>Cochrane Database of Systematic Reviews
Issue number3
Volume2018
Number of pages14
Pages (from-to)1-14
Publication StatusPublished
<mark>Original language</mark>English

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the effectiveness and safety of GLP-1 receptor agonists for Parkinson’s disease.
We will differentiate, as far as possible between neuroprotective and symptomatic effects.

Bibliographic note

This is the Publisher version of record of the following article: Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley HC. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012990. DOI: 10.1002/14651858.CD012990 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012990 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.